COURTNEY WEIR: Open Payments
NPI 1437661170 · JOHNSTOWN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,841 in 284 payments from 37 companies in 2025. Trend: 2023 $3,776 · 2024 $6,229 · 2025 $18,841
Speaker / faculty: $9,863Food & beverage: $7,004Travel & lodging: $1,951Education: $23
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 51 | $13,425 |
| ABBVIE INC. | 37 | $764 |
| Novartis Pharmaceuticals Corporation | 21 | $451 |
| Alexion Pharmaceuticals, Inc. | 13 | $411 |
| ARGENX US, INC. | 9 | $290 |
| Biogen, Inc. | 13 | $250 |
| EMD Serono, Inc. | 9 | $248 |
| Lilly USA, LLC | 9 | $238 |
| Lundbeck LLC | 10 | $237 |
| Axsome Therapeutics, Inc. | 9 | $224 |
Products named: BRIUMVI, KESIMPTA, ULTOMIRIS, QULIPTA, BOTOX, VYEPTI, ACTHAR, Symbravo.
Industry payments across CO — which companies pay providers there.
